Publisher
Springer Berlin Heidelberg
Reference14 articles.
1. American Psychiatric Association (APA) (1998) Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry 155(Suppl):1–34
2. Canadian Coordinating Office of Health Technology Assessment (1997) Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part 11. The cost-effectiveness of SSRIs in treatment of depression. Canadian Coordinating Office for Health Technology Assessment, Ottawa; http://www.ccohta.ca
3. Crott R, Gilis P (1998) Economic comparisons of the pharmacotherapy of depression: An overview. Acta Psychiatrica Scandinavica 97:241–252
4. Fritze J (1998) Kosten-Nutzen-Relation von Antidepressiva. In: Helmchen H, Möller HJ (Hrsg) Psychiatrie für die Praxis 27. MMW Medien & Medizin Verlag, München, S 97–101
5. Fritze J (1999) Therapie mit Neuroleptika aus gesundheits politischer Sicht. In: Möller HJ, Müller N (Hrsg) Atypische Neuroleptika. Steinkopff, Darmstadt, S 123–154